{"gene":"CCR7","run_date":"2026-06-09T22:57:17","timeline":{"discoveries":[{"year":1997,"finding":"ELC (CCL19) was identified as a specific, high-affinity functional ligand for CCR7 (EBI1): ELC-SEAP bound specifically to CCR7-transfected cells, only ELC competed for binding among tested CC chemokines, and ELC induced calcium mobilization and chemotaxis in CCR7-expressing cells.","method":"Receptor-binding assay with alkaline phosphatase fusion protein, calcium mobilization assay, chemotaxis assay in stably transfected cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted binding with fusion protein, calcium flux, and chemotaxis assays in transfected cells; independently corroborated by multiple subsequent studies","pmids":["9153236"],"is_preprint":false},{"year":1998,"finding":"CCR7 is coupled to a Gαi protein: CK beta-11/MIP-3β/ELC-induced chemotaxis and actin polymerization in lymphocytes were completely blocked by pertussis toxin, and ELC induced calcium mobilization that could be cross-desensitized by SDF-1.","method":"Pertussis toxin inhibition of chemotaxis, calcium mobilization assay, actin polymerization assay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 / Strong — pertussis toxin pharmacological dissection of Gαi coupling; replicated across multiple ligand/cell studies","pmids":["9498785"],"is_preprint":false},{"year":1998,"finding":"CCR7 (EBI1) expression is dramatically up-regulated upon dendritic cell maturation (in mouse bone marrow-derived DCs, Langerhans cells, and human monocyte-derived DCs), and the induced CCR7 is functional, mediating calcium mobilization and directional migration toward ELC/MIP-3β in mature but not immature DCs.","method":"Flow cytometry, calcium mobilization assay, chemotaxis assay in mature vs. immature DC cultures","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional receptor assays in three distinct DC culture systems; independently replicated","pmids":["9743376"],"is_preprint":false},{"year":2003,"finding":"Rho kinase (ROCK) is required for CCR7-mediated T lymphocyte polarization and chemotaxis: inhibition with Y-27632 strongly blocked SLC/CCL21- and ELC/CCL19-induced polarized morphology and chemotaxis, whereas ERK2 inhibition had no effect on these processes.","method":"Rho kinase inhibitor (Y-27632) treatment, ERK inhibitor treatment, polarization and chemotaxis assays in T lymphocytes","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — pharmacological dissection with inhibitors, single lab, two readouts but no genetic confirmation","pmids":["12729902"],"is_preprint":false},{"year":2004,"finding":"CCR7 governs entry of both dermal and epidermal dendritic cells into lymphatic vessels within the dermis under inflammatory and steady-state conditions, and is required for the presence of a semimature CD11c+MHCIIhigh DC population in skin-draining lymph nodes, as demonstrated by near-complete absence of these cells in CCR7-deficient mice.","method":"CCR7-deficient mouse analysis, immunohistology, flow cytometry of skin-draining lymph nodes","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function in vivo with defined cellular phenotype; highly cited, independently replicated","pmids":["15308107"],"is_preprint":false},{"year":2004,"finding":"CCR7 is required for intrathymic migration of early T cell progenitors toward the outer cortex: CCR7-deficient mice show disturbed thymic architecture, accumulation of CD25intCD44+ double-negative cells at the cortico-medullary junction, impaired T cell development, and decreased thymocyte numbers; mixed bone marrow chimeras confirmed the cell-intrinsic requirement.","method":"CCR7-deficient mouse analysis, immunohistology, flow cytometry, mixed bone marrow chimeras","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with cell-intrinsic chimera validation and defined positional/developmental phenotype","pmids":["15302903"],"is_preprint":false},{"year":2005,"finding":"CCR7 is a critical signal determining T cell exit from peripheral tissue into afferent lymphatics: CCR7+ but not CCR7− effector T cells migrated from asthmatic lung into afferent lymph and draining lymph nodes, establishing a molecular basis for T cell retrograde tissue egress.","method":"Adoptive transfer of CCR7+ vs. CCR7− T cells into mouse asthmatic lung; flow cytometry of afferent lymph and draining lymph nodes","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct in vivo cell transfer with defined migratory phenotype; single lab but rigorous experimental design","pmids":["16116469"],"is_preprint":false},{"year":2008,"finding":"Distinct C-terminal motifs of CCR7 regulate different signaling outputs: a Ser/Thr motif at the tip of the intracellular tail controls chemokine-mediated Erk1/2 activation; an adjacent regulatory motif modulates this; a region encompassing the full C-terminus is required for G-protein coupling, Ca2+ mobilization, Erk1/2 phosphorylation, and chemotaxis; receptor trafficking/internalization occurs independently of G-protein coupling.","method":"C-terminal deletion mutants and G-protein-coupling-impaired CCR7 mutants; Ca2+ mobilization, Erk1/2 phosphorylation, chemotaxis, and internalization assays","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — structure-function mutagenesis with multiple orthogonal functional assays; single lab","pmids":["18664492"],"is_preprint":false},{"year":2008,"finding":"In secondary lymphoid organs, T cell surface CCR7 is largely occupied by CCL19, leading to continuous signaling and reduced chemotactic responsiveness; both CCL19 and CCL21 trigger CCR7 internalization in vivo; CCR7 occupancy/down-regulation causes strongly impaired chemotactic responses that are reversible by resensitization.","method":"In vivo CCR7 occupancy analysis in Ccl19−/− and plt/plt mice; flow cytometry; in vitro chemotaxis after receptor resensitization","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic mouse models with two ligand knockouts and functional chemotaxis assays; single lab","pmids":["19017956"],"is_preprint":false},{"year":2010,"finding":"The actin-bundling protein L-plastin (LPL) is required for CCR7-mediated T cell polarization and chemotaxis but is dispensable for CCR7 proximal signaling (F-actin polymerization) and CCR7-mediated costimulation: LPL−/− T cells fail to polarize CCR7 to the leading edge upon chemokine stimulation; mature LPL−/− thymocytes show diminished thymic egress in vivo.","method":"LPL−/− mouse, two-photon microscopy of lymphocyte motility, CCR7 localization imaging, chemotaxis assays, thymic egress assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with live imaging and multiple functional readouts separating proximal signaling from polarization/migration","pmids":["20194718"],"is_preprint":false},{"year":2012,"finding":"CCR7 is constitutively ubiquitylated in a ligand-independent manner; upon CCL19 binding, internalized CCR7 recycles back to the plasma membrane via the trans-Golgi network. A ubiquitylation-deficient CCR7 mutant internalizes normally but recycles inefficiently and is retained in the trans-Golgi network, profoundly impairing immune cell migration.","method":"Ubiquitylation-deficient CCR7 mutant; receptor trafficking assays; trans-Golgi network colocalization; immune cell migration assays","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis coupled with mechanistic trafficking assays and functional migration readout; single lab but multiple orthogonal methods","pmids":["22797918"],"is_preprint":false},{"year":2012,"finding":"CCR7/CCL19 signaling activates ERK5, which drives sequential upregulation of the transcription factor KLF-2 and then EDG-1 (S1PR1), thereby controlling T cell egress from lymph nodes; ERK5-deleted T cells (ERK5flox/flox/Lck-Cre) failed to increase migration toward EDG-1 ligands after CCL19 stimulation.","method":"CCL19 stimulation of HuT78 cells and primary murine T cells; ERK5flox/flox/Lck-Cre conditional knockout; Western blot; migration assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional genetic model combined with biochemical pathway analysis; single lab","pmids":["22334704"],"is_preprint":false},{"year":2013,"finding":"CCR7 signaling localizes Treg cells expressing CCR7 to T cell zones of secondary lymphoid tissues where paracrine IL-2 is available, selectively maintaining a CD44loCD62Lhi Treg subset; CCR7lo Tregs in nonlymphoid tissues are IL-2-insensitive and instead depend on ICOS signaling.","method":"CCR7 reporter/KO mice; in vivo IL-2 blockade; ICOS blockade; flow cytometry of tissue-specific Treg subsets","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic and pharmacological dissection of two distinct homeostatic Treg populations with defined localization-function linkage; multiple orthogonal methods","pmids":["24378538"],"is_preprint":false},{"year":2016,"finding":"CCR7 is N-glycosylated at two specific residues (in the N-terminus and the third extracellular loop); the glycosylation pattern modulates receptor sensitivity and endocytosis. Dendritic cells enhance T cell migration toward CCR7 ligands by secreting deglycosylating enzymes that remove sialic acid from CCR7, boosting CCR7 signaling and decreasing receptor endocytosis. DCs also proteolytically convert immobilized CCL21 to a soluble form with distinct signaling properties.","method":"Site-directed mutagenesis of glycosylation sites; metabolic glycan labeling; flow cytometry; migration assays; DC co-culture experiments","journal":"Journal of leukocyte biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis of glycosylation sites with multiple functional readouts; single lab, multiple orthogonal methods","pmids":["26819318"],"is_preprint":false},{"year":2017,"finding":"CCR7 homodimerization directly contributes to CCR7-dependent cell migration and signaling: induction of stable CCR7 homodimers enhanced migration and CCL19 binding, whereas a CCR7-derived synthetic peptide that disrupts homodimers attenuated migration, receptor internalization, actin rearrangement, and Akt/Erk signaling. Induction of CXCR4/CCR7 heterodimers did not enhance migration.","method":"Chemically induced dimerization; CCR7-derived peptide to disrupt dimers; BRET/FRET dimerization assays; chemotaxis, signaling, and internalization assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological induction and disruption of dimers with multiple functional readouts; single lab","pmids":["28819198"],"is_preprint":false},{"year":2017,"finding":"Sulfotyrosine at positions Y8 and Y17 of the CCR7 N-terminus enhances binding to CCL21: NMR showed sulfotyrosine-containing CCR7 peptides have greater affinity than tyrosine or phosphotyrosine peptides; sY8-containing peptides bind near the CCL21 α-helix, sY17-containing peptides bind near the N-loop and β3-strand.","method":"Protein NMR spectroscopy with synthetic sulfopeptides, phosphopeptides, and unmodified peptides; binding affinity measurements","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — rigorous NMR structural characterization, single lab, no cell-based functional validation reported in abstract","pmids":["28841151"],"is_preprint":false},{"year":2018,"finding":"Inhibition of glycolysis impaired CCR7 oligomerization and dendritic cell migration to draining lymph nodes; early glycolytic activation (via AKT, TBK, mTOR) is a common program accompanying DC activation and supports DC migratory ability and elongated cell shape independently of mitochondrial bioenergetics.","method":"Glycolysis inhibition assays; CCR7 oligomerization assays; DC migration to draining lymph nodes in vivo; metabolic profiling","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal assays linking glycolysis to CCR7 oligomerization and DC migration; single lab but rigorous","pmids":["29941886"],"is_preprint":false},{"year":2019,"finding":"CCR7 stimulation activates HIF-1α-dependent glycolytic reprogramming (including Ldha transcription) in dendritic cells to support migration. A CCR7-inducible lncRNA (lnc-Dpf3) feeds back to suppress this by directly binding HIF-1α and blocking its transcriptional activity, thereby limiting DC glycolytic metabolism and migratory capacity. CCR7 stimulation upregulates lnc-Dpf3 via m6A demethylation to prevent RNA degradation.","method":"DC-specific lnc-Dpf3 knockout mice; RIP assay (lnc-Dpf3/HIF-1α interaction); DC migration assays; metabolic assays; m6A modification analysis","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function, biochemical interaction assay, and metabolic/functional readouts; multiple orthogonal methods","pmids":["30824325"],"is_preprint":false},{"year":2019,"finding":"CCR7 uses distinct signaling modules with biased functionality in dendritic cells: the PI3K/Akt pathway controls DC survival, the MAPK pathway controls chemotaxis, and the RhoA pathway controls actin dynamics (migratory speed, cytoarchitecture, and endocytosis); these three pathways function as largely independent modules.","method":"Pharmacological inhibitors of PI3K/Akt, MAPK, and RhoA pathways; functional assays for DC survival, chemotaxis, migration speed, and endocytosis","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological dissection of three distinct signaling pathways with multiple functional readouts; single lab","pmids":["32351499"],"is_preprint":false},{"year":2019,"finding":"CCR7 forms heteromers with CXCR4 during B cell development; upregulation of CCR7 selectively impairs CXCR4's ability to activate certain G-protein complexes, reducing CXCR4 responsiveness to CXCL12 and decreasing B cell retention in bone marrow. CCR7−/− mature B cells display higher CXCL12 responsiveness and increased bone marrow retention.","method":"CCR7−/− mouse; CXCL12-induced calcium flux and chemotaxis assays; BRET-based heteromerization assays; bone marrow retention assays","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function combined with BRET heteromerization and functional assays; single lab","pmids":["31921208"],"is_preprint":false},{"year":2019,"finding":"CCR7 signaling activates the CCR7 → Sp1 → heparanase axis in lung cancer cells: CCL19 stimulation of CCR7 upregulated Sp1 and heparanase mRNA/protein; CCR7 blockade suppressed this; Sp1 inhibition downregulated heparanase; ChIP showed Sp1 binds the heparanase promoter; this pathway promotes cell invasion.","method":"CCL19 stimulation, CCR7 blockade, Sp1 inhibition, chromatin immunoprecipitation (ChIP), invasion assays in A549 cells","journal":"Tumour biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrates direct Sp1-heparanase promoter binding; multiple assays; single lab, single cell line","pmids":["23649655"],"is_preprint":false},{"year":2019,"finding":"CCR7 signaling initiates an endomembrane signaling complex for spatial Rac1 activation during cell migration: CCR7 at the plasma membrane traffics with β-arrestin and Src kinase to endomembranes; Src phosphorylates CCR7 at endomembranes; phospho-CCR7 recruits the RhoGEF Vav1; Vav1 activates Rac1 locally. Photoactivation of Rac1 at endomembranes produced lamellipodia at the leading edge.","method":"Co-immunoprecipitation; Src kinase mutagenesis; vesicular trafficking inhibition; proximity ligation assay; Rac1 photoactivation; cell migration assays in dendritic cells","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted signaling complex with mutagenesis, co-IP, optogenetic validation, and functional migration readout; single lab, multiple orthogonal methods","pmids":["31644919"],"is_preprint":false},{"year":2022,"finding":"ACKR4 (atypical chemokine receptor 4) acts as a scavenger of CCL19 and CCL21 in lymphatic collecting vessel endothelial cells, induced by lymph flow; this enables de-adhesion of T cells in collecting vessels for passive transport to draining lymph nodes. In ACKR4-deficient mice, T cells accumulate in dermal collecting segments and LN migration is reduced despite normal capillary entry.","method":"ACKR4-deficient mice; TPA-induced skin inflammation; flow cytometry; intravital microscopy of lymphatic vessels; endothelial ACKR4 induction by flow","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined spatial phenotype in lymphatics; single lab but in vivo imaging included","pmids":["35108538"],"is_preprint":false},{"year":2023,"finding":"CCR7 acts both as a sensory receptor steering migration and as an effective sink for CCL19: upon ligand binding, DCs internalize CCR7 and ligand via canonical GPCR desensitization, which depletes local CCL19 and self-generates/sharpens chemotactic gradients. This enables collective DC migration, long-range guidance, and gradient sharing with comigrating cells.","method":"Microfluidic gradient chambers; live cell imaging of DC migration; mathematical modeling; CCR7 internalization assays; collective migration analysis","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — experimental data combined with quantitative theory; live imaging of chemokine consumption and gradient dynamics; single lab, multiple orthogonal approaches","pmids":["37656776"],"is_preprint":false},{"year":2007,"finding":"CCR7 mediates corneal antigen-presenting cell trafficking to draining lymph nodes via interaction with CCL21: CCR7+ CD11b+CD11c+ cells localized near LYVE-1+ lymphatic vessels in inflamed corneas; CCR7+ OVA-loaded APCs appeared in draining LNs 48h after transplantation; local anti-CCL21 antibody neutralization significantly suppressed OVA+CD11c+ cell flow to draining LNs.","method":"Corneal transplant with fluorescent OVA tracking; anti-CCL21 neutralizing antibody injection; flow cytometry; immunofluorescence","journal":"Molecular vision","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo antigen tracking with neutralizing antibody functional block; single lab","pmids":["17515886"],"is_preprint":false},{"year":2006,"finding":"Endothelins induce CCR7 expression in breast tumor cells via endothelin receptor A and HIF-1α: endothelin stimulation stabilized HIF-1α, which drove CCR7 transcription; dominant-negative HIF-1α abolished CCR7 induction; CCR7-dependent endothelin-mediated invasion was blocked by anti-CCR7 antibody.","method":"Dominant-negative HIF-1α transfection; iron chelator treatment; CCR7-neutralizing antibody; invasion assay; flow cytometry","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic dominant-negative approach with pharmacological validation; single lab, multiple assays","pmids":["17178876"],"is_preprint":false},{"year":2007,"finding":"CCR7 signaling inhibits T cell proliferation and induces cell cycle arrest: sustained high concentrations of CCL19 or CCL21 (soluble or immobilized) specifically blocked proliferation and IL-2 secretion in CCR7+ T cells (human and murine CD4+ and CD8+); this was associated with delayed degradation of p27Kip1 and down-regulation of CDK1; CCR7−/− T cells showed normal proliferation unaffected by CCL19.","method":"CCR7−/− mouse T cells; proliferation assays; ELISA for IL-2; Western blot for p27Kip1 and CDK1; comparison of soluble vs. immobilized ligands","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function control combined with biochemical cell cycle analysis; single lab, multiple cell types","pmids":["17982037"],"is_preprint":false},{"year":2009,"finding":"Jak3 is required for CCR7-mediated dendritic cell migration: Jak3−/− DCs show impaired chemotactic responses to CCL19 and CCL21 both in vitro and in vivo, and reduced DC-mediated T lymphocyte activation, while DC generation from bone marrow progenitors is unaffected.","method":"Jak3−/− mice; in vitro and in vivo DC chemotaxis assays; mixed lymphocyte reactions; contact hypersensitivity assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with both in vitro and in vivo migration readouts; single lab","pmids":["19759904"],"is_preprint":false},{"year":2016,"finding":"CCR7 limits Treg recirculation back to the thymus: CCR7 defines bona fide Rag2GFP+ Treg precursors in the thymus, but CCR7 is not required for Treg production or emigration; lack of CCR7 renders the thymus more receptive to Treg thymus homing, revealing CCR7 functions to restrict re-entry of peripheral Tregs.","method":"Rag2pGFPCcr7−/− mice; intrathymic labeling; flow cytometry; thymic Treg precursor developmental analysis","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with Rag2 reporter, distinguishing production from recirculation; single lab","pmids":["26832402"],"is_preprint":false},{"year":2014,"finding":"Epigenetic silencing via H3K27me3 at the Ccr7 promoter restricts CCR7 expression to conventional DCs (cDCs) but not monocyte-derived DCs (moDCs): moDCs were enriched for H3K27me3 at the Ccr7 locus compared to migratory cDCs, explaining their failure to migrate efficiently to lymph nodes. This silencing occurs gradually during monocyte-to-moDC differentiation rather than at early lineage commitment.","method":"ChIP for H3K27me3 at Ccr7 locus in lung DC subsets; bone marrow-derived DC cultures; in vivo DC migration assays","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with functional migration readout; single lab","pmids":["25297875"],"is_preprint":false},{"year":2015,"finding":"FOXO1 transcriptionally regulates CCR7 expression in dendritic cells: FOXO1 binds the CCR7 promoter directly, stimulates CCR7 transcriptional activity, and regulates CCR7 expression; rescue of FOXO1-deleted DCs with both CCR7 and ICAM-1 expression reverses impaired DC homing to lymph nodes in vivo.","method":"FOXO1 promoter-binding ChIP; transcriptional activity assay; conditional FOXO1 knockout (CD11c.Cre); rescue transfection; in vivo DC homing assay","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with genetic rescue; single lab, multiple orthogonal methods","pmids":["25786691"],"is_preprint":false},{"year":2023,"finding":"CCR7 activates PI3Kγ signaling in ALK+ ALCL lymphoma cells as a survival pathway; endothelial-derived CCL19/CCL21 protected ALCL cells from crizotinib-induced apoptosis in a 3D microfluidic chip; genetic deletion of CCR7 blocked CNS dissemination and perivascular growth of ALCL in crizotinib-treated mice; dual PI3Kγ/δ inhibition with duvelisib potentiated crizotinib activity.","method":"3D microfluidic chip; CCR7 genetic deletion in mouse ALCL model; PI3Kγ/δ inhibitor (duvelisib) combination; patient-derived xenografts","journal":"Science translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic CCR7 deletion in vivo combined with 3D microfluidic assay and PDX; single lab but multiple model systems","pmids":["37379367"],"is_preprint":false},{"year":2022,"finding":"CCR7 mediates neutrophil migration from inflamed or infected skin to draining lymph nodes via lymphatic vessels; in the dLNs, CCR7+ neutrophils are phagocytosed by cDC1 and cDC2; CCR7-specific deficiency in neutrophils increased antistaphylococcal immunity and aggravated skin inflammation, establishing a regulatory role for CCR7-dependent neutrophil LN homing in cutaneous immunity.","method":"Conditional CCR7-deficient neutrophils; photoconvertible mouse tracking; Staphylococcus aureus skin infection model; TLR-induced inflammation; flow cytometry","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — cell-type-specific CCR7 deletion with in vivo tracking and defined immunological phenotype; single lab, multiple models","pmids":["35119939"],"is_preprint":false},{"year":1995,"finding":"BLR2/EBI1/CCR7 mRNA expression is specifically transactivated by Epstein-Barr virus nuclear antigen 2 (EBNA2): estrogen-inducible EBNA2 in EBV-negative BL41 cells drove BLR2 transcription, identifying EBNA2 as a transcriptional activator of CCR7 in B cells.","method":"Northern blot; estrogen-inducible EBNA2 expression system in EBV-negative BL41 cells; RT-PCR","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — inducible transcription factor system; single lab, single method","pmids":["7488016"],"is_preprint":false}],"current_model":"CCR7 is a seven-transmembrane Gαi-coupled chemokine receptor whose two ligands, CCL19 and CCL21, drive directional migration of dendritic cells and lymphocytes into secondary lymphoid organs; its intracellular C-terminus mediates G-protein coupling, Ca2+ mobilization, and ERK activation through distinct motifs, while receptor ubiquitylation enables post-endocytic recycling via the trans-Golgi network; CCR7 homodimerization and N-glycosylation fine-tune ligand sensitivity and endocytosis; Rho kinase, L-plastin-dependent actin bundling, Jak3, and an endomembrane Src–Vav1–Rac1 complex are required downstream effectors for cell polarization and migration; CCR7 also acts as a chemokine sink that self-shapes CCL19 gradients to coordinate collective migration, inhibits T cell proliferation via p27Kip1/CDK1, controls thymic progenitor positioning and γδ T cell development, mediates neutrophil clearance in draining lymph nodes, and drives a CCL19→ERK5→KLF2→S1PR1 axis governing lymph node egress."},"narrative":{"mechanistic_narrative":"CCR7 is a Gαi-coupled seven-transmembrane chemokine receptor that drives directional and collective migration of dendritic cells and lymphocytes into and within secondary lymphoid organs in response to its ligands CCL19 (ELC) and CCL21 (SLC) [PMID:9153236, PMID:9498785, PMID:15308107]. Ligand engagement triggers calcium mobilization, actin polymerization, and chemotaxis that are abolished by pertussis toxin, establishing Gαi-dependence [PMID:9153236, PMID:9498785], and the receptor is sharply upregulated on dendritic cells during maturation to license their migration toward CCL19/CCL21 [PMID:9743376]. Signaling outputs are partitioned across distinct C-terminal motifs and largely independent downstream modules: a Ser/Thr tail motif controls ERK1/2 activation while the full C-terminus is required for G-protein coupling, with internalization occurring independently of G-protein coupling [PMID:18664492], and PI3K/Akt, MAPK, and RhoA modules separately govern DC survival, chemotaxis, and actin dynamics [PMID:32351499]. Polarization and migration require ROCK, the actin-bundling protein L-plastin, and Jak3 [PMID:12729902, PMID:20194718, PMID:19759904], and CCR7 nucleates an endomembrane signaling complex in which β-arrestin- and Src-dependent trafficking leads to Src phosphorylation of CCR7, Vav1 recruitment, and local Rac1 activation that generates leading-edge lamellipodia [PMID:31644919]. Receptor behavior is tuned by constitutive ubiquitylation enabling post-endocytic recycling through the trans-Golgi network [PMID:22797918], by N-glycosylation and tyrosine sulfation that modulate ligand sensitivity and endocytosis [PMID:26819318, PMID:28841151], and by homodimerization/oligomerization that is itself supported by glycolytic metabolism [PMID:28819198, PMID:29941886]. Beyond steering individual cells, CCR7 acts as a chemokine sink, internalizing CCL19 to self-generate and sharpen gradients for long-range collective DC guidance [PMID:37656776]. CCR7 governs key positional decisions in immunity: dendritic cell entry into lymphatics and lymph nodes [PMID:15308107], intrathymic progenitor positioning and T cell development [PMID:15302903], T cell egress from peripheral tissue into afferent lymph [PMID:16116469], lymph node egress via a CCL19→ERK5→KLF2→S1PR1 axis [PMID:22334704], Treg localization and homeostasis [PMID:24378538], and neutrophil clearance into draining lymph nodes [PMID:35119939]. CCR7 also functions as a pro-tumoral and survival signal in cancer, driving invasion via a HIF-1α and Sp1/heparanase program and PI3Kγ-dependent survival in lymphoma [PMID:23649655, PMID:17178876, PMID:37379367].","teleology":[{"year":1995,"claim":"Established a transcriptional input to CCR7 expression before its ligand or function was known, linking the orphan receptor BLR2/EBI1 to viral B cell transformation programs.","evidence":"Estrogen-inducible EBNA2 expression in EBV-negative BL41 cells with Northern/RT-PCR","pmids":["7488016"],"confidence":"Medium","gaps":["Does not define the receptor's ligand or signaling function","Single inducible system, no direct promoter occupancy shown"]},{"year":1997,"claim":"Deorphanized CCR7 by identifying CCL19 (ELC) as a specific high-affinity functional ligand, converting an orphan receptor into a defined chemotactic receptor.","evidence":"Alkaline phosphatase fusion binding, calcium flux, and chemotaxis in transfected cells","pmids":["9153236"],"confidence":"High","gaps":["Did not yet identify CCL21 as a second ligand","G-protein coupling not yet dissected"]},{"year":1998,"claim":"Defined the transducer class by showing CCR7 signals through Gαi and is induced upon DC maturation, connecting receptor biochemistry to a physiological cell state.","evidence":"Pertussis toxin inhibition of chemotaxis/actin polymerization; flow cytometry and functional assays in maturing DCs","pmids":["9498785","9743376"],"confidence":"High","gaps":["Downstream effectors beyond Gαi not identified","Mechanism of maturation-induced upregulation not defined"]},{"year":2003,"claim":"Began dissecting downstream effectors, placing Rho kinase but not ERK2 in the polarization/chemotaxis pathway.","evidence":"Y-27632 and ERK inhibitor treatment with polarization/chemotaxis readouts in T cells","pmids":["12729902"],"confidence":"Medium","gaps":["Pharmacological only, no genetic confirmation","Does not map the GEF or GTPase linking CCR7 to ROCK"]},{"year":2004,"claim":"Established the in vivo physiological role of CCR7 in DC entry into lymphatics/lymph nodes and intrathymic progenitor positioning, moving from cell-based assays to organismal immunology.","evidence":"CCR7-deficient mice, immunohistology, flow cytometry, mixed bone marrow chimeras","pmids":["15308107","15302903"],"confidence":"High","gaps":["Does not resolve the molecular signaling required for these positioning events","Ligand contributions (CCL19 vs CCL21) not separated"]},{"year":2005,"claim":"Extended CCR7 function to retrograde T cell egress from peripheral tissue into afferent lymph, defining a molecular basis for tissue exit.","evidence":"Adoptive transfer of CCR7+ vs CCR7- effector T cells in asthmatic lung","pmids":["16116469"],"confidence":"High","gaps":["Signaling downstream of CCR7 in this context not defined","Single tissue/disease model"]},{"year":2006,"claim":"Linked CCR7 to tumor biology by showing endothelin/HIF-1α-driven CCR7 induction promotes invasion, framing CCR7 as a hijacked metastatic effector.","evidence":"Dominant-negative HIF-1α, CCR7-neutralizing antibody, invasion assays in breast tumor cells","pmids":["17178876"],"confidence":"Medium","gaps":["Single cancer cell context","Does not establish in vivo metastatic requirement"]},{"year":2007,"claim":"Demonstrated context-specific antigen-presenting cell trafficking via CCL21 and uncovered an unexpected anti-proliferative function of CCR7 signaling.","evidence":"Corneal APC tracking with anti-CCL21 neutralization; CCR7-/- T cell proliferation with p27Kip1/CDK1 Western blots","pmids":["17515886","17982037"],"confidence":"Medium","gaps":["Mechanism coupling CCR7 to cell-cycle machinery not fully mapped","Single-lab studies"]},{"year":2008,"claim":"Defined the structure-function logic of the CCR7 C-terminus and showed ligand occupancy in lymphoid organs continuously desensitizes the receptor in vivo.","evidence":"C-terminal deletion/coupling-dead mutants with multiple functional assays; in vivo occupancy in Ccl19-/- and plt/plt mice","pmids":["18664492","19017956"],"confidence":"High","gaps":["Internalization machinery (adaptors, kinases) not identified at this stage","Resensitization mechanism in vivo not resolved"]},{"year":2009,"claim":"Identified Jak3 as a required effector for CCR7-driven DC migration, expanding the downstream effector network beyond classical GPCR components.","evidence":"Jak3-/- mice with in vitro/in vivo DC chemotaxis and MLR assays","pmids":["19759904"],"confidence":"Medium","gaps":["Biochemical link between CCR7 and Jak3 not established","Single lab"]},{"year":2010,"claim":"Separated proximal CCR7 signaling from cytoskeletal polarization by showing L-plastin is required for receptor polarization and migration but not F-actin polymerization.","evidence":"LPL-/- mice, two-photon imaging, CCR7 localization, chemotaxis and thymic egress assays","pmids":["20194718"],"confidence":"High","gaps":["How CCR7 signaling activates L-plastin not defined","Connection to ROCK/RhoA modules unresolved"]},{"year":2012,"claim":"Revealed receptor trafficking control: constitutive ubiquitylation enables TGN-mediated recycling, and an egress signaling axis (ERK5→KLF2→S1PR1) was placed downstream of CCR7.","evidence":"Ubiquitylation-deficient mutant trafficking assays; ERK5 conditional knockout with migration assays","pmids":["22797918","22334704"],"confidence":"High","gaps":["The ubiquitin ligase acting on CCR7 not identified","ERK5 axis tested in limited cell models"]},{"year":2013,"claim":"Connected CCR7-dependent localization to homeostatic function, showing CCR7 positions Tregs in IL-2-rich T cell zones to maintain a specific Treg subset.","evidence":"CCR7 reporter/KO mice, in vivo IL-2 and ICOS blockade, flow cytometry","pmids":["24378538"],"confidence":"High","gaps":["Does not address CCR7 signaling intermediates in Tregs","Tissue-specific ligand sources not mapped"]},{"year":2014,"claim":"Established epigenetic and transcriptional control of CCR7 expression that determines which DC subsets can migrate to lymph nodes.","evidence":"ChIP for H3K27me3 at Ccr7 in DC subsets; FOXO1 promoter ChIP and genetic rescue (reported 2015)","pmids":["25297875","25786691"],"confidence":"Medium","gaps":["Upstream signals controlling these marks/FOXO1 activity not defined","Single-lab ChIP studies"]},{"year":2016,"claim":"Showed post-translational glycosylation tunes CCR7 ligand sensitivity and endocytosis, and that CCR7 restricts Treg recirculation back to the thymus, refining its functional repertoire.","evidence":"Glycosylation-site mutagenesis with migration/endocytosis assays; Rag2pGFPCcr7-/- thymic Treg analysis","pmids":["26819318","26832402"],"confidence":"High","gaps":["Enzymes deglycosylating CCR7 in vivo not fully characterized","Mechanism of CCR7-mediated thymic re-entry restriction unclear"]},{"year":2017,"claim":"Defined biophysical determinants of CCR7 function: homodimerization enhances migration/signaling, and N-terminal sulfotyrosines (Y8, Y17) boost CCL21 binding.","evidence":"Chemically induced dimerization and disruptor peptide with BRET/FRET; NMR of sulfopeptide-CCL21 binding","pmids":["28819198","28841151"],"confidence":"Medium","gaps":["NMR sulfotyrosine study lacks cell-based functional validation","Endogenous regulation of sulfation/dimerization not established"]},{"year":2018,"claim":"Linked cellular metabolism to receptor biophysics, showing glycolysis supports CCR7 oligomerization and DC migratory capacity.","evidence":"Glycolysis inhibition, oligomerization assays, in vivo DC migration, metabolic profiling","pmids":["29941886"],"confidence":"High","gaps":["Molecular link between glycolytic flux and oligomerization not defined","Single lab"]},{"year":2019,"claim":"Resolved CCR7 signaling into spatially organized and modular outputs and uncovered metabolic feedback, including an endomembrane Src-Vav1-Rac1 complex, independent PI3K/MAPK/RhoA modules, HIF-1α glycolytic reprogramming with lnc-Dpf3 feedback, and CXCR4 heteromerization.","evidence":"Co-IP, Src mutagenesis, Rac1 photoactivation, pharmacological module dissection, DC-specific lnc-Dpf3 KO with RIP, BRET heteromerization assays","pmids":["31644919","32351499","30824325","31921208"],"confidence":"High","gaps":["Integration of the modular pathways into a unified migratory program incomplete","In vivo relevance of CXCR4 heteromer effects limited to B cell models"]},{"year":2022,"claim":"Established CCR7's role in neutrophil clearance to draining lymph nodes and revealed ACKR4-mediated CCL19/CCL21 scavenging as an external regulator enabling lymphatic transport.","evidence":"Neutrophil-specific CCR7 deletion with photoconvertible tracking and S. aureus model; ACKR4-deficient mice with intravital lymphatic imaging","pmids":["35119939","35108538"],"confidence":"High","gaps":["Crosstalk between cell-intrinsic CCR7 signaling and ACKR4 scavenging not fully integrated","Mechanism of cDC phagocytosis of CCR7+ neutrophils not detailed"]},{"year":2023,"claim":"Demonstrated CCR7 acts as a chemokine sink shaping its own gradients for collective migration, and as a PI3Kγ-dependent survival signal exploited by lymphoma.","evidence":"Microfluidic gradient chambers with live imaging and modeling; CCR7 genetic deletion in ALCL model with PI3Kγ/δ inhibition and PDX","pmids":["37656776","37379367"],"confidence":"High","gaps":["In vivo confirmation of self-generated gradients in tissue not established","Therapeutic targeting of CCR7-PI3Kγ axis only tested in limited lymphoma models"]},{"year":null,"claim":"How the distinct CCR7 signaling modules, trafficking states, post-translational modifications, and dimerization are integrated in space and time to produce a single coherent migratory response remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified structural model linking C-terminal motifs, ubiquitylation, glycosylation, and dimerization","The ubiquitin ligase and deglycosylating enzymes acting on CCR7 in vivo are unidentified","Quantitative rules governing ligand discrimination between CCL19 and CCL21 signaling outcomes are incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1,7]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[22]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[10,21]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[10]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[21]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,7,21]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[4,5,6,32]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[0,2,23]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[20,25,31]}],"complexes":["CCR7 homodimer","CCR7-CXCR4 heteromer","endomembrane CCR7-Src-Vav1-Rac1 signaling complex"],"partners":["CCL19","CCL21","CXCR4","SRC","VAV1","ARRB (Β-ARRESTIN)","RAC1","ACKR4"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P32248","full_name":"C-C chemokine receptor type 7","aliases":["BLR2","CDw197","Epstein-Barr virus-induced G-protein coupled receptor 1","EBI1","EBV-induced G-protein coupled receptor 1","MIP-3 beta receptor"],"length_aa":378,"mass_kda":42.9,"function":"Receptor for the MIP-3-beta chemokine. Probable mediator of EBV effects on B-lymphocytes or of normal lymphocyte functions","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P32248/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CCR7","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CCR7","total_profiled":1310},"omim":[{"mim_id":"617237","title":"IMMUNODEFICIENCY 49, SEVERE COMBINED; IMD49","url":"https://www.omim.org/entry/617237"},{"mim_id":"611195","title":"JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 1; JAKMIP1","url":"https://www.omim.org/entry/611195"},{"mim_id":"610369","title":"HEAT-SHOCK 70-KD PROTEIN 14; HSPA14","url":"https://www.omim.org/entry/610369"},{"mim_id":"609662","title":"NLR FAMILY, PYRIN DOMAIN-CONTAINING 10; NLRP10","url":"https://www.omim.org/entry/609662"},{"mim_id":"608957","title":"IMMUNODEFICIENCY 116; IMD116","url":"https://www.omim.org/entry/608957"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Mitochondria","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":19.7},{"tissue":"lymphoid tissue","ntpm":78.7}],"url":"https://www.proteinatlas.org/search/CCR7"},"hgnc":{"alias_symbol":["BLR2","CDw197","CD197"],"prev_symbol":["CMKBR7","EBI1"]},"alphafold":{"accession":"P32248","domains":[{"cath_id":"1.20.1070.10","chopping":"50-338","consensus_level":"medium","plddt":86.1547,"start":50,"end":338}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P32248","model_url":"https://alphafold.ebi.ac.uk/files/AF-P32248-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P32248-F1-predicted_aligned_error_v6.png","plddt_mean":78.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CCR7","jax_strain_url":"https://www.jax.org/strain/search?query=CCR7"},"sequence":{"accession":"P32248","fasta_url":"https://rest.uniprot.org/uniprotkb/P32248.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P32248/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P32248"}},"corpus_meta":[{"pmid":"18379575","id":"PMC_18379575","title":"CCR7 and its ligands: balancing immunity and tolerance.","date":"2008","source":"Nature reviews. Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18379575","citation_count":1151,"is_preprint":false},{"pmid":"15308107","id":"PMC_15308107","title":"CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions.","date":"2004","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15308107","citation_count":805,"is_preprint":false},{"pmid":"16116469","id":"PMC_16116469","title":"Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics.","date":"2005","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16116469","citation_count":420,"is_preprint":false},{"pmid":"9153236","id":"PMC_9153236","title":"Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9153236","citation_count":325,"is_preprint":false},{"pmid":"24378538","id":"PMC_24378538","title":"CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets.","date":"2013","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24378538","citation_count":321,"is_preprint":false},{"pmid":"30824325","id":"PMC_30824325","title":"CCR7 Chemokine Receptor-Inducible lnc-Dpf3 Restrains Dendritic Cell Migration by Inhibiting HIF-1α-Mediated Glycolysis.","date":"2019","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/30824325","citation_count":302,"is_preprint":false},{"pmid":"9743376","id":"PMC_9743376","title":"EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9743376","citation_count":286,"is_preprint":false},{"pmid":"12019175","id":"PMC_12019175","title":"Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma.","date":"2002","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12019175","citation_count":266,"is_preprint":false},{"pmid":"11145663","id":"PMC_11145663","title":"CCR7 expression and memory T cell diversity in humans.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11145663","citation_count":255,"is_preprint":false},{"pmid":"16203865","id":"PMC_16203865","title":"IL-18-induced CD83+CCR7+ NK helper cells.","date":"2005","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16203865","citation_count":236,"is_preprint":false},{"pmid":"15122702","id":"PMC_15122702","title":"Expression of CCR7 in multiple sclerosis: implications for CNS immunity.","date":"2004","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15122702","citation_count":223,"is_preprint":false},{"pmid":"29941886","id":"PMC_29941886","title":"Glycolytic metabolism is essential for CCR7 oligomerization and dendritic cell migration.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29941886","citation_count":177,"is_preprint":false},{"pmid":"31632965","id":"PMC_31632965","title":"CCL19 and CCR7 Expression, Signaling Pathways, and Adjuvant Functions in Viral Infection and Prevention.","date":"2019","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/31632965","citation_count":162,"is_preprint":false},{"pmid":"26729814","id":"PMC_26729814","title":"Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes.","date":"2016","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/26729814","citation_count":159,"is_preprint":false},{"pmid":"15302903","id":"PMC_15302903","title":"Thymic T cell development and progenitor localization depend on CCR7.","date":"2004","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15302903","citation_count":157,"is_preprint":false},{"pmid":"15073111","id":"PMC_15073111","title":"CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.","date":"2004","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/15073111","citation_count":151,"is_preprint":false},{"pmid":"34361107","id":"PMC_34361107","title":"Dendritic Cells and CCR7 Expression: An Important Factor for Autoimmune Diseases, Chronic Inflammation, and Cancer.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34361107","citation_count":111,"is_preprint":false},{"pmid":"10607681","id":"PMC_10607681","title":"Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10607681","citation_count":107,"is_preprint":false},{"pmid":"9498785","id":"PMC_9498785","title":"CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9498785","citation_count":102,"is_preprint":false},{"pmid":"33385485","id":"PMC_33385485","title":"CCR7 as a therapeutic target in Cancer.","date":"2020","source":"Biochimica et biophysica acta. Reviews on cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33385485","citation_count":94,"is_preprint":false},{"pmid":"10878344","id":"PMC_10878344","title":"Cytokines and cell surface molecules independently induce CXCR4 expression on CD4+ CCR7+ human memory T cells.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10878344","citation_count":92,"is_preprint":false},{"pmid":"32017846","id":"PMC_32017846","title":"CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32017846","citation_count":88,"is_preprint":false},{"pmid":"9701028","id":"PMC_9701028","title":"EBI1-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: activated T cells strongly up-regulate CCR7 and efficiently migrate toward ELC.","date":"1998","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9701028","citation_count":86,"is_preprint":false},{"pmid":"32340161","id":"PMC_32340161","title":"The Role of CCL21/CCR7 Chemokine Axis in Breast Cancer Progression.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32340161","citation_count":80,"is_preprint":false},{"pmid":"7488016","id":"PMC_7488016","title":"Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2.","date":"1995","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/7488016","citation_count":77,"is_preprint":false},{"pmid":"7851893","id":"PMC_7851893","title":"Cloning of human and mouse EBI1, a lymphoid-specific G-protein-coupled receptor encoded on human chromosome 17q12-q21.2.","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7851893","citation_count":76,"is_preprint":false},{"pmid":"35281921","id":"PMC_35281921","title":"New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35281921","citation_count":75,"is_preprint":false},{"pmid":"15557160","id":"PMC_15557160","title":"Impact of CCR7 on priming and distribution of antiviral effector and memory CTL.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15557160","citation_count":71,"is_preprint":false},{"pmid":"17515886","id":"PMC_17515886","title":"The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking.","date":"2007","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/17515886","citation_count":70,"is_preprint":false},{"pmid":"26819318","id":"PMC_26819318","title":"Distinct CCR7 glycosylation pattern shapes receptor signaling and endocytosis to modulate chemotactic responses.","date":"2016","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/26819318","citation_count":67,"is_preprint":false},{"pmid":"25019368","id":"PMC_25019368","title":"CCR7: roles in cancer cell dissemination, migration and metastasis formation.","date":"2014","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25019368","citation_count":64,"is_preprint":false},{"pmid":"24725321","id":"PMC_24725321","title":"The chemokine receptor CCR7 expressed by dendritic cells: a key player in corneal and ocular surface inflammation.","date":"2013","source":"The ocular surface","url":"https://pubmed.ncbi.nlm.nih.gov/24725321","citation_count":58,"is_preprint":false},{"pmid":"26832402","id":"PMC_26832402","title":"CCR7 Controls Thymus Recirculation, but Not Production and Emigration, of Foxp3(+) T Cells.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26832402","citation_count":58,"is_preprint":false},{"pmid":"17337767","id":"PMC_17337767","title":"CCR7 mediates inflammation-associated tumor progression.","date":"2006","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/17337767","citation_count":57,"is_preprint":false},{"pmid":"38267413","id":"PMC_38267413","title":"Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38267413","citation_count":55,"is_preprint":false},{"pmid":"10861057","id":"PMC_10861057","title":"Macrophage-derived chemokine and EBI1-ligand chemokine attract human thymocytes in different stage of development and are produced by distinct subsets of medullary epithelial cells: possible implications for negative selection.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10861057","citation_count":55,"is_preprint":false},{"pmid":"9725259","id":"PMC_9725259","title":"Macrophage-inflammatory protein-3 beta/EBI1-ligand chemokine/CK beta-11, a CC chemokine, is a chemoattractant with a specificity for macrophage progenitors among myeloid progenitor cells.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9725259","citation_count":55,"is_preprint":false},{"pmid":"17065406","id":"PMC_17065406","title":"Expression and function of the chemokine receptor CCR7 in thyroid carcinomas.","date":"2006","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17065406","citation_count":54,"is_preprint":false},{"pmid":"12729902","id":"PMC_12729902","title":"Rho kinase is required for CCR7-mediated polarization and chemotaxis of T lymphocytes.","date":"2003","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12729902","citation_count":53,"is_preprint":false},{"pmid":"17178876","id":"PMC_17178876","title":"Endothelins induce CCR7 expression by breast tumor cells via endothelin receptor A and hypoxia-inducible factor-1.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17178876","citation_count":53,"is_preprint":false},{"pmid":"29973648","id":"PMC_29973648","title":"The chemokine receptor CCR7 is a promising target for rheumatoid arthritis therapy.","date":"2018","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29973648","citation_count":52,"is_preprint":false},{"pmid":"27248053","id":"PMC_27248053","title":"CXCR4 and CCR7: Two eligible targets in targeted cancer therapy.","date":"2016","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/27248053","citation_count":52,"is_preprint":false},{"pmid":"28819198","id":"PMC_28819198","title":"Regulation of CCR7-dependent cell migration through CCR7 homodimer formation.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28819198","citation_count":51,"is_preprint":false},{"pmid":"22700449","id":"PMC_22700449","title":"Multifaceted activities of CCR7 regulate T-cell homeostasis in health and disease.","date":"2012","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22700449","citation_count":51,"is_preprint":false},{"pmid":"12851649","id":"PMC_12851649","title":"Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking.","date":"2003","source":"Microcirculation (New York, N.Y. : 1994)","url":"https://pubmed.ncbi.nlm.nih.gov/12851649","citation_count":51,"is_preprint":false},{"pmid":"25786691","id":"PMC_25786691","title":"FOXO1 regulates dendritic cell activity through ICAM-1 and CCR7.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25786691","citation_count":50,"is_preprint":false},{"pmid":"18544997","id":"PMC_18544997","title":"Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer.","date":"2008","source":"Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/18544997","citation_count":49,"is_preprint":false},{"pmid":"32351499","id":"PMC_32351499","title":"The Chemokine Receptor CCR7 Uses Distinct Signaling Modules With Biased Functionality to Regulate Dendritic Cells.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32351499","citation_count":47,"is_preprint":false},{"pmid":"18838387","id":"PMC_18838387","title":"Functional expression of the chemokine receptor CCR7 on fibroblast-like synoviocytes.","date":"2008","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18838387","citation_count":44,"is_preprint":false},{"pmid":"27774094","id":"PMC_27774094","title":"Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor.","date":"2016","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27774094","citation_count":44,"is_preprint":false},{"pmid":"37656776","id":"PMC_37656776","title":"CCR7 acts as both a sensor and a sink for CCL19 to coordinate collective leukocyte migration.","date":"2023","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37656776","citation_count":43,"is_preprint":false},{"pmid":"20194718","id":"PMC_20194718","title":"The actin-bundling protein L-plastin dissociates CCR7 proximal signaling from CCR7-induced motility.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20194718","citation_count":43,"is_preprint":false},{"pmid":"25139737","id":"PMC_25139737","title":"CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/25139737","citation_count":43,"is_preprint":false},{"pmid":"22797918","id":"PMC_22797918","title":"Ubiquitylation of the chemokine receptor CCR7 enables efficient receptor recycling and cell migration.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/22797918","citation_count":42,"is_preprint":false},{"pmid":"19017956","id":"PMC_19017956","title":"Dynamic modulation of CCR7 expression and function on naive T lymphocytes in vivo.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19017956","citation_count":40,"is_preprint":false},{"pmid":"23649655","id":"PMC_23649655","title":"CCL19/CCR7 upregulates heparanase via specificity protein-1 (Sp1) to promote invasion of cell in lung cancer.","date":"2013","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23649655","citation_count":40,"is_preprint":false},{"pmid":"18664492","id":"PMC_18664492","title":"Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis.","date":"2008","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/18664492","citation_count":40,"is_preprint":false},{"pmid":"24990231","id":"PMC_24990231","title":"Contribution of homeostatic chemokines CCL19 and CCL21 and their receptor CCR7 to coronary artery disease.","date":"2014","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24990231","citation_count":40,"is_preprint":false},{"pmid":"17982037","id":"PMC_17982037","title":"CCR7 signaling inhibits T cell proliferation.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17982037","citation_count":39,"is_preprint":false},{"pmid":"31921208","id":"PMC_31921208","title":"Coexpression of CCR7 and CXCR4 During B Cell Development Controls CXCR4 Responsiveness and Bone Marrow Homing.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31921208","citation_count":38,"is_preprint":false},{"pmid":"21195108","id":"PMC_21195108","title":"Chicken CCR6 and CCR7 are markers for immature and mature dendritic cells respectively.","date":"2010","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21195108","citation_count":36,"is_preprint":false},{"pmid":"32499193","id":"PMC_32499193","title":"The pathogenic importance of CCL21 and CCR7 in rheumatoid arthritis.","date":"2020","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/32499193","citation_count":35,"is_preprint":false},{"pmid":"27207557","id":"PMC_27207557","title":"CCR7 Maintains Nonresolving Lymph Node and Adipose Inflammation in Obesity.","date":"2016","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/27207557","citation_count":35,"is_preprint":false},{"pmid":"25772241","id":"PMC_25772241","title":"The chemokine receptor CCR7 promotes mammary tumorigenesis through amplification of stem-like cells.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/25772241","citation_count":35,"is_preprint":false},{"pmid":"37331295","id":"PMC_37331295","title":"CCL21/CCR7 axis as a therapeutic target for autoimmune diseases.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37331295","citation_count":34,"is_preprint":false},{"pmid":"28416768","id":"PMC_28416768","title":"Tumor hypoxia modulates podoplanin/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28416768","citation_count":33,"is_preprint":false},{"pmid":"16223574","id":"PMC_16223574","title":"Oral and oropharyngeal squamous cell carcinomas expressing CCR7 have poor prognoses.","date":"2005","source":"Auris, nasus, larynx","url":"https://pubmed.ncbi.nlm.nih.gov/16223574","citation_count":33,"is_preprint":false},{"pmid":"16786131","id":"PMC_16786131","title":"Chemokine receptor CCR7 enhances intrahepatic and lymphatic dissemination of human hepatocellular cancer.","date":"2006","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/16786131","citation_count":32,"is_preprint":false},{"pmid":"16394278","id":"PMC_16394278","title":"Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia.","date":"2006","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16394278","citation_count":32,"is_preprint":false},{"pmid":"26504105","id":"PMC_26504105","title":"Differential ligand-signaling network of CCL19/CCL21-CCR7 system.","date":"2015","source":"Database : the journal of biological databases and curation","url":"https://pubmed.ncbi.nlm.nih.gov/26504105","citation_count":32,"is_preprint":false},{"pmid":"25297875","id":"PMC_25297875","title":"Epigenetic control of Ccr7 expression in distinct lineages of lung dendritic cells.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25297875","citation_count":32,"is_preprint":false},{"pmid":"31644919","id":"PMC_31644919","title":"Chemokine Receptor CCR7 Triggers an Endomembrane Signaling Complex for Spatial Rac Activation.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31644919","citation_count":29,"is_preprint":false},{"pmid":"35119939","id":"PMC_35119939","title":"CCR7-guided neutrophil redirection to skin-draining lymph nodes regulates cutaneous inflammation and infection.","date":"2022","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35119939","citation_count":29,"is_preprint":false},{"pmid":"19759904","id":"PMC_19759904","title":"Jak3 is involved in dendritic cell maturation and CCR7-dependent migration.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19759904","citation_count":29,"is_preprint":false},{"pmid":"32564199","id":"PMC_32564199","title":"CCL19 suppresses gastric cancer cell proliferation, migration, and invasion through the CCL19/CCR7/AIM2 pathway.","date":"2020","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/32564199","citation_count":29,"is_preprint":false},{"pmid":"20638137","id":"PMC_20638137","title":"CCR7 is expressed in astrocytes and upregulated after an inflammatory injury.","date":"2010","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/20638137","citation_count":29,"is_preprint":false},{"pmid":"20028772","id":"PMC_20028772","title":"CCR7 regulates lymphocyte egress and recirculation through body cavities.","date":"2009","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/20028772","citation_count":28,"is_preprint":false},{"pmid":"35108538","id":"PMC_35108538","title":"Mechanosensitive ACKR4 scavenges CCR7 chemokines to facilitate T cell de-adhesion and passive transport by flow in inflamed afferent lymphatics.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35108538","citation_count":28,"is_preprint":false},{"pmid":"16189151","id":"PMC_16189151","title":"Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn's disease.","date":"2005","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16189151","citation_count":27,"is_preprint":false},{"pmid":"28694053","id":"PMC_28694053","title":"Biased signaling of G protein-coupled receptors - From a chemokine receptor CCR7 perspective.","date":"2017","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28694053","citation_count":27,"is_preprint":false},{"pmid":"31068931","id":"PMC_31068931","title":"Elevated CCL19/CCR7 Expression During the Disease Process of Primary Sjögren's Syndrome.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31068931","citation_count":27,"is_preprint":false},{"pmid":"33110606","id":"PMC_33110606","title":"CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia.","date":"2020","source":"Biomarker research","url":"https://pubmed.ncbi.nlm.nih.gov/33110606","citation_count":27,"is_preprint":false},{"pmid":"25257053","id":"PMC_25257053","title":"Dry eye-induced CCR7+CD11b+ cell lymph node homing is induced by COX-2 activities.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/25257053","citation_count":27,"is_preprint":false},{"pmid":"30518137","id":"PMC_30518137","title":"Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30518137","citation_count":26,"is_preprint":false},{"pmid":"22334704","id":"PMC_22334704","title":"CCR7/CCL19 controls expression of EDG-1 in T cells.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22334704","citation_count":26,"is_preprint":false},{"pmid":"35133060","id":"PMC_35133060","title":"CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels.","date":"2022","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/35133060","citation_count":24,"is_preprint":false},{"pmid":"24528991","id":"PMC_24528991","title":"Correlation between CCR7 expression and lymph node metastatic potential of human tongue carcinoma.","date":"2014","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24528991","citation_count":24,"is_preprint":false},{"pmid":"21969271","id":"PMC_21969271","title":"Deficient CCR7 signaling promotes TH2 polarization and B-cell activation in vivo.","date":"2011","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21969271","citation_count":24,"is_preprint":false},{"pmid":"28137279","id":"PMC_28137279","title":"Interplay between CCR7 and Notch1 axes promotes stemness in MMTV-PyMT mammary cancer cells.","date":"2017","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28137279","citation_count":24,"is_preprint":false},{"pmid":"24500801","id":"PMC_24500801","title":"CCR7-mediated migration in the thymus controls γδ T-cell development.","date":"2014","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24500801","citation_count":23,"is_preprint":false},{"pmid":"37314567","id":"PMC_37314567","title":"CCL21-CCR7 signaling promotes microglia/macrophage recruitment and chemotherapy resistance in glioblastoma.","date":"2023","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/37314567","citation_count":22,"is_preprint":false},{"pmid":"25613752","id":"PMC_25613752","title":"Curcumin treatment suppresses CCR7 expression and the differentiation and migration of human circulating fibrocytes.","date":"2015","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25613752","citation_count":22,"is_preprint":false},{"pmid":"22619482","id":"PMC_22619482","title":"oxLDL downregulates the dendritic cell homing factors CCR7 and CCL21.","date":"2012","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/22619482","citation_count":22,"is_preprint":false},{"pmid":"31504210","id":"PMC_31504210","title":"Down-regulation of CCR7 via AKT pathway and GATA2 inactivation suppressed trophoblast migration and invasion in recurrent spontaneous abortion†.","date":"2020","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/31504210","citation_count":22,"is_preprint":false},{"pmid":"37379367","id":"PMC_37379367","title":"Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma.","date":"2023","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37379367","citation_count":20,"is_preprint":false},{"pmid":"30785638","id":"PMC_30785638","title":"CCL21-expression and accumulation of CCR7+ NK cells in livers of patients with primary sclerosing cholangitis.","date":"2019","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30785638","citation_count":20,"is_preprint":false},{"pmid":"28841151","id":"PMC_28841151","title":"CCR7 Sulfotyrosine Enhances CCL21 Binding.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28841151","citation_count":19,"is_preprint":false},{"pmid":"34778050","id":"PMC_34778050","title":"CCR7 in Blood Cancers - Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34778050","citation_count":19,"is_preprint":false},{"pmid":"18606672","id":"PMC_18606672","title":"SOCS1 regulates CCR7 expression and migration of CD4+ T cells into peripheral tissues.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18606672","citation_count":19,"is_preprint":false},{"pmid":"17850582","id":"PMC_17850582","title":"Expression of chemokine receptors CCR7 and CCR8 in the CNS during ChREAE.","date":"2007","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17850582","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46606,"output_tokens":8654,"usd":0.134814,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18680,"output_tokens":6176,"usd":0.1239,"stage2_stop_reason":"end_turn"},"total_usd":0.258714,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"ELC (CCL19) was identified as a specific, high-affinity functional ligand for CCR7 (EBI1): ELC-SEAP bound specifically to CCR7-transfected cells, only ELC competed for binding among tested CC chemokines, and ELC induced calcium mobilization and chemotaxis in CCR7-expressing cells.\",\n      \"method\": \"Receptor-binding assay with alkaline phosphatase fusion protein, calcium mobilization assay, chemotaxis assay in stably transfected cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted binding with fusion protein, calcium flux, and chemotaxis assays in transfected cells; independently corroborated by multiple subsequent studies\",\n      \"pmids\": [\"9153236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CCR7 is coupled to a Gαi protein: CK beta-11/MIP-3β/ELC-induced chemotaxis and actin polymerization in lymphocytes were completely blocked by pertussis toxin, and ELC induced calcium mobilization that could be cross-desensitized by SDF-1.\",\n      \"method\": \"Pertussis toxin inhibition of chemotaxis, calcium mobilization assay, actin polymerization assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — pertussis toxin pharmacological dissection of Gαi coupling; replicated across multiple ligand/cell studies\",\n      \"pmids\": [\"9498785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CCR7 (EBI1) expression is dramatically up-regulated upon dendritic cell maturation (in mouse bone marrow-derived DCs, Langerhans cells, and human monocyte-derived DCs), and the induced CCR7 is functional, mediating calcium mobilization and directional migration toward ELC/MIP-3β in mature but not immature DCs.\",\n      \"method\": \"Flow cytometry, calcium mobilization assay, chemotaxis assay in mature vs. immature DC cultures\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional receptor assays in three distinct DC culture systems; independently replicated\",\n      \"pmids\": [\"9743376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Rho kinase (ROCK) is required for CCR7-mediated T lymphocyte polarization and chemotaxis: inhibition with Y-27632 strongly blocked SLC/CCL21- and ELC/CCL19-induced polarized morphology and chemotaxis, whereas ERK2 inhibition had no effect on these processes.\",\n      \"method\": \"Rho kinase inhibitor (Y-27632) treatment, ERK inhibitor treatment, polarization and chemotaxis assays in T lymphocytes\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — pharmacological dissection with inhibitors, single lab, two readouts but no genetic confirmation\",\n      \"pmids\": [\"12729902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CCR7 governs entry of both dermal and epidermal dendritic cells into lymphatic vessels within the dermis under inflammatory and steady-state conditions, and is required for the presence of a semimature CD11c+MHCIIhigh DC population in skin-draining lymph nodes, as demonstrated by near-complete absence of these cells in CCR7-deficient mice.\",\n      \"method\": \"CCR7-deficient mouse analysis, immunohistology, flow cytometry of skin-draining lymph nodes\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function in vivo with defined cellular phenotype; highly cited, independently replicated\",\n      \"pmids\": [\"15308107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CCR7 is required for intrathymic migration of early T cell progenitors toward the outer cortex: CCR7-deficient mice show disturbed thymic architecture, accumulation of CD25intCD44+ double-negative cells at the cortico-medullary junction, impaired T cell development, and decreased thymocyte numbers; mixed bone marrow chimeras confirmed the cell-intrinsic requirement.\",\n      \"method\": \"CCR7-deficient mouse analysis, immunohistology, flow cytometry, mixed bone marrow chimeras\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with cell-intrinsic chimera validation and defined positional/developmental phenotype\",\n      \"pmids\": [\"15302903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CCR7 is a critical signal determining T cell exit from peripheral tissue into afferent lymphatics: CCR7+ but not CCR7− effector T cells migrated from asthmatic lung into afferent lymph and draining lymph nodes, establishing a molecular basis for T cell retrograde tissue egress.\",\n      \"method\": \"Adoptive transfer of CCR7+ vs. CCR7− T cells into mouse asthmatic lung; flow cytometry of afferent lymph and draining lymph nodes\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct in vivo cell transfer with defined migratory phenotype; single lab but rigorous experimental design\",\n      \"pmids\": [\"16116469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Distinct C-terminal motifs of CCR7 regulate different signaling outputs: a Ser/Thr motif at the tip of the intracellular tail controls chemokine-mediated Erk1/2 activation; an adjacent regulatory motif modulates this; a region encompassing the full C-terminus is required for G-protein coupling, Ca2+ mobilization, Erk1/2 phosphorylation, and chemotaxis; receptor trafficking/internalization occurs independently of G-protein coupling.\",\n      \"method\": \"C-terminal deletion mutants and G-protein-coupling-impaired CCR7 mutants; Ca2+ mobilization, Erk1/2 phosphorylation, chemotaxis, and internalization assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structure-function mutagenesis with multiple orthogonal functional assays; single lab\",\n      \"pmids\": [\"18664492\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In secondary lymphoid organs, T cell surface CCR7 is largely occupied by CCL19, leading to continuous signaling and reduced chemotactic responsiveness; both CCL19 and CCL21 trigger CCR7 internalization in vivo; CCR7 occupancy/down-regulation causes strongly impaired chemotactic responses that are reversible by resensitization.\",\n      \"method\": \"In vivo CCR7 occupancy analysis in Ccl19−/− and plt/plt mice; flow cytometry; in vitro chemotaxis after receptor resensitization\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic mouse models with two ligand knockouts and functional chemotaxis assays; single lab\",\n      \"pmids\": [\"19017956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The actin-bundling protein L-plastin (LPL) is required for CCR7-mediated T cell polarization and chemotaxis but is dispensable for CCR7 proximal signaling (F-actin polymerization) and CCR7-mediated costimulation: LPL−/− T cells fail to polarize CCR7 to the leading edge upon chemokine stimulation; mature LPL−/− thymocytes show diminished thymic egress in vivo.\",\n      \"method\": \"LPL−/− mouse, two-photon microscopy of lymphocyte motility, CCR7 localization imaging, chemotaxis assays, thymic egress assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with live imaging and multiple functional readouts separating proximal signaling from polarization/migration\",\n      \"pmids\": [\"20194718\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CCR7 is constitutively ubiquitylated in a ligand-independent manner; upon CCL19 binding, internalized CCR7 recycles back to the plasma membrane via the trans-Golgi network. A ubiquitylation-deficient CCR7 mutant internalizes normally but recycles inefficiently and is retained in the trans-Golgi network, profoundly impairing immune cell migration.\",\n      \"method\": \"Ubiquitylation-deficient CCR7 mutant; receptor trafficking assays; trans-Golgi network colocalization; immune cell migration assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis coupled with mechanistic trafficking assays and functional migration readout; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"22797918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CCR7/CCL19 signaling activates ERK5, which drives sequential upregulation of the transcription factor KLF-2 and then EDG-1 (S1PR1), thereby controlling T cell egress from lymph nodes; ERK5-deleted T cells (ERK5flox/flox/Lck-Cre) failed to increase migration toward EDG-1 ligands after CCL19 stimulation.\",\n      \"method\": \"CCL19 stimulation of HuT78 cells and primary murine T cells; ERK5flox/flox/Lck-Cre conditional knockout; Western blot; migration assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional genetic model combined with biochemical pathway analysis; single lab\",\n      \"pmids\": [\"22334704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CCR7 signaling localizes Treg cells expressing CCR7 to T cell zones of secondary lymphoid tissues where paracrine IL-2 is available, selectively maintaining a CD44loCD62Lhi Treg subset; CCR7lo Tregs in nonlymphoid tissues are IL-2-insensitive and instead depend on ICOS signaling.\",\n      \"method\": \"CCR7 reporter/KO mice; in vivo IL-2 blockade; ICOS blockade; flow cytometry of tissue-specific Treg subsets\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic and pharmacological dissection of two distinct homeostatic Treg populations with defined localization-function linkage; multiple orthogonal methods\",\n      \"pmids\": [\"24378538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CCR7 is N-glycosylated at two specific residues (in the N-terminus and the third extracellular loop); the glycosylation pattern modulates receptor sensitivity and endocytosis. Dendritic cells enhance T cell migration toward CCR7 ligands by secreting deglycosylating enzymes that remove sialic acid from CCR7, boosting CCR7 signaling and decreasing receptor endocytosis. DCs also proteolytically convert immobilized CCL21 to a soluble form with distinct signaling properties.\",\n      \"method\": \"Site-directed mutagenesis of glycosylation sites; metabolic glycan labeling; flow cytometry; migration assays; DC co-culture experiments\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of glycosylation sites with multiple functional readouts; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"26819318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CCR7 homodimerization directly contributes to CCR7-dependent cell migration and signaling: induction of stable CCR7 homodimers enhanced migration and CCL19 binding, whereas a CCR7-derived synthetic peptide that disrupts homodimers attenuated migration, receptor internalization, actin rearrangement, and Akt/Erk signaling. Induction of CXCR4/CCR7 heterodimers did not enhance migration.\",\n      \"method\": \"Chemically induced dimerization; CCR7-derived peptide to disrupt dimers; BRET/FRET dimerization assays; chemotaxis, signaling, and internalization assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological induction and disruption of dimers with multiple functional readouts; single lab\",\n      \"pmids\": [\"28819198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Sulfotyrosine at positions Y8 and Y17 of the CCR7 N-terminus enhances binding to CCL21: NMR showed sulfotyrosine-containing CCR7 peptides have greater affinity than tyrosine or phosphotyrosine peptides; sY8-containing peptides bind near the CCL21 α-helix, sY17-containing peptides bind near the N-loop and β3-strand.\",\n      \"method\": \"Protein NMR spectroscopy with synthetic sulfopeptides, phosphopeptides, and unmodified peptides; binding affinity measurements\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — rigorous NMR structural characterization, single lab, no cell-based functional validation reported in abstract\",\n      \"pmids\": [\"28841151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Inhibition of glycolysis impaired CCR7 oligomerization and dendritic cell migration to draining lymph nodes; early glycolytic activation (via AKT, TBK, mTOR) is a common program accompanying DC activation and supports DC migratory ability and elongated cell shape independently of mitochondrial bioenergetics.\",\n      \"method\": \"Glycolysis inhibition assays; CCR7 oligomerization assays; DC migration to draining lymph nodes in vivo; metabolic profiling\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal assays linking glycolysis to CCR7 oligomerization and DC migration; single lab but rigorous\",\n      \"pmids\": [\"29941886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CCR7 stimulation activates HIF-1α-dependent glycolytic reprogramming (including Ldha transcription) in dendritic cells to support migration. A CCR7-inducible lncRNA (lnc-Dpf3) feeds back to suppress this by directly binding HIF-1α and blocking its transcriptional activity, thereby limiting DC glycolytic metabolism and migratory capacity. CCR7 stimulation upregulates lnc-Dpf3 via m6A demethylation to prevent RNA degradation.\",\n      \"method\": \"DC-specific lnc-Dpf3 knockout mice; RIP assay (lnc-Dpf3/HIF-1α interaction); DC migration assays; metabolic assays; m6A modification analysis\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function, biochemical interaction assay, and metabolic/functional readouts; multiple orthogonal methods\",\n      \"pmids\": [\"30824325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CCR7 uses distinct signaling modules with biased functionality in dendritic cells: the PI3K/Akt pathway controls DC survival, the MAPK pathway controls chemotaxis, and the RhoA pathway controls actin dynamics (migratory speed, cytoarchitecture, and endocytosis); these three pathways function as largely independent modules.\",\n      \"method\": \"Pharmacological inhibitors of PI3K/Akt, MAPK, and RhoA pathways; functional assays for DC survival, chemotaxis, migration speed, and endocytosis\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological dissection of three distinct signaling pathways with multiple functional readouts; single lab\",\n      \"pmids\": [\"32351499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CCR7 forms heteromers with CXCR4 during B cell development; upregulation of CCR7 selectively impairs CXCR4's ability to activate certain G-protein complexes, reducing CXCR4 responsiveness to CXCL12 and decreasing B cell retention in bone marrow. CCR7−/− mature B cells display higher CXCL12 responsiveness and increased bone marrow retention.\",\n      \"method\": \"CCR7−/− mouse; CXCL12-induced calcium flux and chemotaxis assays; BRET-based heteromerization assays; bone marrow retention assays\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function combined with BRET heteromerization and functional assays; single lab\",\n      \"pmids\": [\"31921208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CCR7 signaling activates the CCR7 → Sp1 → heparanase axis in lung cancer cells: CCL19 stimulation of CCR7 upregulated Sp1 and heparanase mRNA/protein; CCR7 blockade suppressed this; Sp1 inhibition downregulated heparanase; ChIP showed Sp1 binds the heparanase promoter; this pathway promotes cell invasion.\",\n      \"method\": \"CCL19 stimulation, CCR7 blockade, Sp1 inhibition, chromatin immunoprecipitation (ChIP), invasion assays in A549 cells\",\n      \"journal\": \"Tumour biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrates direct Sp1-heparanase promoter binding; multiple assays; single lab, single cell line\",\n      \"pmids\": [\"23649655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CCR7 signaling initiates an endomembrane signaling complex for spatial Rac1 activation during cell migration: CCR7 at the plasma membrane traffics with β-arrestin and Src kinase to endomembranes; Src phosphorylates CCR7 at endomembranes; phospho-CCR7 recruits the RhoGEF Vav1; Vav1 activates Rac1 locally. Photoactivation of Rac1 at endomembranes produced lamellipodia at the leading edge.\",\n      \"method\": \"Co-immunoprecipitation; Src kinase mutagenesis; vesicular trafficking inhibition; proximity ligation assay; Rac1 photoactivation; cell migration assays in dendritic cells\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted signaling complex with mutagenesis, co-IP, optogenetic validation, and functional migration readout; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"31644919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ACKR4 (atypical chemokine receptor 4) acts as a scavenger of CCL19 and CCL21 in lymphatic collecting vessel endothelial cells, induced by lymph flow; this enables de-adhesion of T cells in collecting vessels for passive transport to draining lymph nodes. In ACKR4-deficient mice, T cells accumulate in dermal collecting segments and LN migration is reduced despite normal capillary entry.\",\n      \"method\": \"ACKR4-deficient mice; TPA-induced skin inflammation; flow cytometry; intravital microscopy of lymphatic vessels; endothelial ACKR4 induction by flow\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined spatial phenotype in lymphatics; single lab but in vivo imaging included\",\n      \"pmids\": [\"35108538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CCR7 acts both as a sensory receptor steering migration and as an effective sink for CCL19: upon ligand binding, DCs internalize CCR7 and ligand via canonical GPCR desensitization, which depletes local CCL19 and self-generates/sharpens chemotactic gradients. This enables collective DC migration, long-range guidance, and gradient sharing with comigrating cells.\",\n      \"method\": \"Microfluidic gradient chambers; live cell imaging of DC migration; mathematical modeling; CCR7 internalization assays; collective migration analysis\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — experimental data combined with quantitative theory; live imaging of chemokine consumption and gradient dynamics; single lab, multiple orthogonal approaches\",\n      \"pmids\": [\"37656776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CCR7 mediates corneal antigen-presenting cell trafficking to draining lymph nodes via interaction with CCL21: CCR7+ CD11b+CD11c+ cells localized near LYVE-1+ lymphatic vessels in inflamed corneas; CCR7+ OVA-loaded APCs appeared in draining LNs 48h after transplantation; local anti-CCL21 antibody neutralization significantly suppressed OVA+CD11c+ cell flow to draining LNs.\",\n      \"method\": \"Corneal transplant with fluorescent OVA tracking; anti-CCL21 neutralizing antibody injection; flow cytometry; immunofluorescence\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo antigen tracking with neutralizing antibody functional block; single lab\",\n      \"pmids\": [\"17515886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Endothelins induce CCR7 expression in breast tumor cells via endothelin receptor A and HIF-1α: endothelin stimulation stabilized HIF-1α, which drove CCR7 transcription; dominant-negative HIF-1α abolished CCR7 induction; CCR7-dependent endothelin-mediated invasion was blocked by anti-CCR7 antibody.\",\n      \"method\": \"Dominant-negative HIF-1α transfection; iron chelator treatment; CCR7-neutralizing antibody; invasion assay; flow cytometry\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic dominant-negative approach with pharmacological validation; single lab, multiple assays\",\n      \"pmids\": [\"17178876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CCR7 signaling inhibits T cell proliferation and induces cell cycle arrest: sustained high concentrations of CCL19 or CCL21 (soluble or immobilized) specifically blocked proliferation and IL-2 secretion in CCR7+ T cells (human and murine CD4+ and CD8+); this was associated with delayed degradation of p27Kip1 and down-regulation of CDK1; CCR7−/− T cells showed normal proliferation unaffected by CCL19.\",\n      \"method\": \"CCR7−/− mouse T cells; proliferation assays; ELISA for IL-2; Western blot for p27Kip1 and CDK1; comparison of soluble vs. immobilized ligands\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function control combined with biochemical cell cycle analysis; single lab, multiple cell types\",\n      \"pmids\": [\"17982037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Jak3 is required for CCR7-mediated dendritic cell migration: Jak3−/− DCs show impaired chemotactic responses to CCL19 and CCL21 both in vitro and in vivo, and reduced DC-mediated T lymphocyte activation, while DC generation from bone marrow progenitors is unaffected.\",\n      \"method\": \"Jak3−/− mice; in vitro and in vivo DC chemotaxis assays; mixed lymphocyte reactions; contact hypersensitivity assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with both in vitro and in vivo migration readouts; single lab\",\n      \"pmids\": [\"19759904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CCR7 limits Treg recirculation back to the thymus: CCR7 defines bona fide Rag2GFP+ Treg precursors in the thymus, but CCR7 is not required for Treg production or emigration; lack of CCR7 renders the thymus more receptive to Treg thymus homing, revealing CCR7 functions to restrict re-entry of peripheral Tregs.\",\n      \"method\": \"Rag2pGFPCcr7−/− mice; intrathymic labeling; flow cytometry; thymic Treg precursor developmental analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with Rag2 reporter, distinguishing production from recirculation; single lab\",\n      \"pmids\": [\"26832402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Epigenetic silencing via H3K27me3 at the Ccr7 promoter restricts CCR7 expression to conventional DCs (cDCs) but not monocyte-derived DCs (moDCs): moDCs were enriched for H3K27me3 at the Ccr7 locus compared to migratory cDCs, explaining their failure to migrate efficiently to lymph nodes. This silencing occurs gradually during monocyte-to-moDC differentiation rather than at early lineage commitment.\",\n      \"method\": \"ChIP for H3K27me3 at Ccr7 locus in lung DC subsets; bone marrow-derived DC cultures; in vivo DC migration assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with functional migration readout; single lab\",\n      \"pmids\": [\"25297875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FOXO1 transcriptionally regulates CCR7 expression in dendritic cells: FOXO1 binds the CCR7 promoter directly, stimulates CCR7 transcriptional activity, and regulates CCR7 expression; rescue of FOXO1-deleted DCs with both CCR7 and ICAM-1 expression reverses impaired DC homing to lymph nodes in vivo.\",\n      \"method\": \"FOXO1 promoter-binding ChIP; transcriptional activity assay; conditional FOXO1 knockout (CD11c.Cre); rescue transfection; in vivo DC homing assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with genetic rescue; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"25786691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CCR7 activates PI3Kγ signaling in ALK+ ALCL lymphoma cells as a survival pathway; endothelial-derived CCL19/CCL21 protected ALCL cells from crizotinib-induced apoptosis in a 3D microfluidic chip; genetic deletion of CCR7 blocked CNS dissemination and perivascular growth of ALCL in crizotinib-treated mice; dual PI3Kγ/δ inhibition with duvelisib potentiated crizotinib activity.\",\n      \"method\": \"3D microfluidic chip; CCR7 genetic deletion in mouse ALCL model; PI3Kγ/δ inhibitor (duvelisib) combination; patient-derived xenografts\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic CCR7 deletion in vivo combined with 3D microfluidic assay and PDX; single lab but multiple model systems\",\n      \"pmids\": [\"37379367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CCR7 mediates neutrophil migration from inflamed or infected skin to draining lymph nodes via lymphatic vessels; in the dLNs, CCR7+ neutrophils are phagocytosed by cDC1 and cDC2; CCR7-specific deficiency in neutrophils increased antistaphylococcal immunity and aggravated skin inflammation, establishing a regulatory role for CCR7-dependent neutrophil LN homing in cutaneous immunity.\",\n      \"method\": \"Conditional CCR7-deficient neutrophils; photoconvertible mouse tracking; Staphylococcus aureus skin infection model; TLR-induced inflammation; flow cytometry\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific CCR7 deletion with in vivo tracking and defined immunological phenotype; single lab, multiple models\",\n      \"pmids\": [\"35119939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"BLR2/EBI1/CCR7 mRNA expression is specifically transactivated by Epstein-Barr virus nuclear antigen 2 (EBNA2): estrogen-inducible EBNA2 in EBV-negative BL41 cells drove BLR2 transcription, identifying EBNA2 as a transcriptional activator of CCR7 in B cells.\",\n      \"method\": \"Northern blot; estrogen-inducible EBNA2 expression system in EBV-negative BL41 cells; RT-PCR\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — inducible transcription factor system; single lab, single method\",\n      \"pmids\": [\"7488016\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CCR7 is a seven-transmembrane Gαi-coupled chemokine receptor whose two ligands, CCL19 and CCL21, drive directional migration of dendritic cells and lymphocytes into secondary lymphoid organs; its intracellular C-terminus mediates G-protein coupling, Ca2+ mobilization, and ERK activation through distinct motifs, while receptor ubiquitylation enables post-endocytic recycling via the trans-Golgi network; CCR7 homodimerization and N-glycosylation fine-tune ligand sensitivity and endocytosis; Rho kinase, L-plastin-dependent actin bundling, Jak3, and an endomembrane Src–Vav1–Rac1 complex are required downstream effectors for cell polarization and migration; CCR7 also acts as a chemokine sink that self-shapes CCL19 gradients to coordinate collective migration, inhibits T cell proliferation via p27Kip1/CDK1, controls thymic progenitor positioning and γδ T cell development, mediates neutrophil clearance in draining lymph nodes, and drives a CCL19→ERK5→KLF2→S1PR1 axis governing lymph node egress.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CCR7 is a Gαi-coupled seven-transmembrane chemokine receptor that drives directional and collective migration of dendritic cells and lymphocytes into and within secondary lymphoid organs in response to its ligands CCL19 (ELC) and CCL21 (SLC) [#0, #1, #4]. Ligand engagement triggers calcium mobilization, actin polymerization, and chemotaxis that are abolished by pertussis toxin, establishing Gαi-dependence [#0, #1], and the receptor is sharply upregulated on dendritic cells during maturation to license their migration toward CCL19/CCL21 [#2]. Signaling outputs are partitioned across distinct C-terminal motifs and largely independent downstream modules: a Ser/Thr tail motif controls ERK1/2 activation while the full C-terminus is required for G-protein coupling, with internalization occurring independently of G-protein coupling [#7], and PI3K/Akt, MAPK, and RhoA modules separately govern DC survival, chemotaxis, and actin dynamics [#18]. Polarization and migration require ROCK, the actin-bundling protein L-plastin, and Jak3 [#3, #9, #27], and CCR7 nucleates an endomembrane signaling complex in which β-arrestin- and Src-dependent trafficking leads to Src phosphorylation of CCR7, Vav1 recruitment, and local Rac1 activation that generates leading-edge lamellipodia [#21]. Receptor behavior is tuned by constitutive ubiquitylation enabling post-endocytic recycling through the trans-Golgi network [#10], by N-glycosylation and tyrosine sulfation that modulate ligand sensitivity and endocytosis [#13, #15], and by homodimerization/oligomerization that is itself supported by glycolytic metabolism [#14, #16]. Beyond steering individual cells, CCR7 acts as a chemokine sink, internalizing CCL19 to self-generate and sharpen gradients for long-range collective DC guidance [#23]. CCR7 governs key positional decisions in immunity: dendritic cell entry into lymphatics and lymph nodes [#4], intrathymic progenitor positioning and T cell development [#5], T cell egress from peripheral tissue into afferent lymph [#6], lymph node egress via a CCL19→ERK5→KLF2→S1PR1 axis [#11], Treg localization and homeostasis [#12], and neutrophil clearance into draining lymph nodes [#32]. CCR7 also functions as a pro-tumoral and survival signal in cancer, driving invasion via a HIF-1α and Sp1/heparanase program and PI3Kγ-dependent survival in lymphoma [#20, #25, #31].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established a transcriptional input to CCR7 expression before its ligand or function was known, linking the orphan receptor BLR2/EBI1 to viral B cell transformation programs.\",\n      \"evidence\": \"Estrogen-inducible EBNA2 expression in EBV-negative BL41 cells with Northern/RT-PCR\",\n      \"pmids\": [\"7488016\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not define the receptor's ligand or signaling function\", \"Single inducible system, no direct promoter occupancy shown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Deorphanized CCR7 by identifying CCL19 (ELC) as a specific high-affinity functional ligand, converting an orphan receptor into a defined chemotactic receptor.\",\n      \"evidence\": \"Alkaline phosphatase fusion binding, calcium flux, and chemotaxis in transfected cells\",\n      \"pmids\": [\"9153236\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not yet identify CCL21 as a second ligand\", \"G-protein coupling not yet dissected\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined the transducer class by showing CCR7 signals through Gαi and is induced upon DC maturation, connecting receptor biochemistry to a physiological cell state.\",\n      \"evidence\": \"Pertussis toxin inhibition of chemotaxis/actin polymerization; flow cytometry and functional assays in maturing DCs\",\n      \"pmids\": [\"9498785\", \"9743376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effectors beyond Gαi not identified\", \"Mechanism of maturation-induced upregulation not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Began dissecting downstream effectors, placing Rho kinase but not ERK2 in the polarization/chemotaxis pathway.\",\n      \"evidence\": \"Y-27632 and ERK inhibitor treatment with polarization/chemotaxis readouts in T cells\",\n      \"pmids\": [\"12729902\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Pharmacological only, no genetic confirmation\", \"Does not map the GEF or GTPase linking CCR7 to ROCK\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Established the in vivo physiological role of CCR7 in DC entry into lymphatics/lymph nodes and intrathymic progenitor positioning, moving from cell-based assays to organismal immunology.\",\n      \"evidence\": \"CCR7-deficient mice, immunohistology, flow cytometry, mixed bone marrow chimeras\",\n      \"pmids\": [\"15308107\", \"15302903\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not resolve the molecular signaling required for these positioning events\", \"Ligand contributions (CCL19 vs CCL21) not separated\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Extended CCR7 function to retrograde T cell egress from peripheral tissue into afferent lymph, defining a molecular basis for tissue exit.\",\n      \"evidence\": \"Adoptive transfer of CCR7+ vs CCR7- effector T cells in asthmatic lung\",\n      \"pmids\": [\"16116469\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling downstream of CCR7 in this context not defined\", \"Single tissue/disease model\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Linked CCR7 to tumor biology by showing endothelin/HIF-1α-driven CCR7 induction promotes invasion, framing CCR7 as a hijacked metastatic effector.\",\n      \"evidence\": \"Dominant-negative HIF-1α, CCR7-neutralizing antibody, invasion assays in breast tumor cells\",\n      \"pmids\": [\"17178876\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cancer cell context\", \"Does not establish in vivo metastatic requirement\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrated context-specific antigen-presenting cell trafficking via CCL21 and uncovered an unexpected anti-proliferative function of CCR7 signaling.\",\n      \"evidence\": \"Corneal APC tracking with anti-CCL21 neutralization; CCR7-/- T cell proliferation with p27Kip1/CDK1 Western blots\",\n      \"pmids\": [\"17515886\", \"17982037\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism coupling CCR7 to cell-cycle machinery not fully mapped\", \"Single-lab studies\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined the structure-function logic of the CCR7 C-terminus and showed ligand occupancy in lymphoid organs continuously desensitizes the receptor in vivo.\",\n      \"evidence\": \"C-terminal deletion/coupling-dead mutants with multiple functional assays; in vivo occupancy in Ccl19-/- and plt/plt mice\",\n      \"pmids\": [\"18664492\", \"19017956\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Internalization machinery (adaptors, kinases) not identified at this stage\", \"Resensitization mechanism in vivo not resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identified Jak3 as a required effector for CCR7-driven DC migration, expanding the downstream effector network beyond classical GPCR components.\",\n      \"evidence\": \"Jak3-/- mice with in vitro/in vivo DC chemotaxis and MLR assays\",\n      \"pmids\": [\"19759904\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Biochemical link between CCR7 and Jak3 not established\", \"Single lab\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Separated proximal CCR7 signaling from cytoskeletal polarization by showing L-plastin is required for receptor polarization and migration but not F-actin polymerization.\",\n      \"evidence\": \"LPL-/- mice, two-photon imaging, CCR7 localization, chemotaxis and thymic egress assays\",\n      \"pmids\": [\"20194718\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CCR7 signaling activates L-plastin not defined\", \"Connection to ROCK/RhoA modules unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Revealed receptor trafficking control: constitutive ubiquitylation enables TGN-mediated recycling, and an egress signaling axis (ERK5→KLF2→S1PR1) was placed downstream of CCR7.\",\n      \"evidence\": \"Ubiquitylation-deficient mutant trafficking assays; ERK5 conditional knockout with migration assays\",\n      \"pmids\": [\"22797918\", \"22334704\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The ubiquitin ligase acting on CCR7 not identified\", \"ERK5 axis tested in limited cell models\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Connected CCR7-dependent localization to homeostatic function, showing CCR7 positions Tregs in IL-2-rich T cell zones to maintain a specific Treg subset.\",\n      \"evidence\": \"CCR7 reporter/KO mice, in vivo IL-2 and ICOS blockade, flow cytometry\",\n      \"pmids\": [\"24378538\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address CCR7 signaling intermediates in Tregs\", \"Tissue-specific ligand sources not mapped\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established epigenetic and transcriptional control of CCR7 expression that determines which DC subsets can migrate to lymph nodes.\",\n      \"evidence\": \"ChIP for H3K27me3 at Ccr7 in DC subsets; FOXO1 promoter ChIP and genetic rescue (reported 2015)\",\n      \"pmids\": [\"25297875\", \"25786691\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Upstream signals controlling these marks/FOXO1 activity not defined\", \"Single-lab ChIP studies\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed post-translational glycosylation tunes CCR7 ligand sensitivity and endocytosis, and that CCR7 restricts Treg recirculation back to the thymus, refining its functional repertoire.\",\n      \"evidence\": \"Glycosylation-site mutagenesis with migration/endocytosis assays; Rag2pGFPCcr7-/- thymic Treg analysis\",\n      \"pmids\": [\"26819318\", \"26832402\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Enzymes deglycosylating CCR7 in vivo not fully characterized\", \"Mechanism of CCR7-mediated thymic re-entry restriction unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined biophysical determinants of CCR7 function: homodimerization enhances migration/signaling, and N-terminal sulfotyrosines (Y8, Y17) boost CCL21 binding.\",\n      \"evidence\": \"Chemically induced dimerization and disruptor peptide with BRET/FRET; NMR of sulfopeptide-CCL21 binding\",\n      \"pmids\": [\"28819198\", \"28841151\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"NMR sulfotyrosine study lacks cell-based functional validation\", \"Endogenous regulation of sulfation/dimerization not established\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linked cellular metabolism to receptor biophysics, showing glycolysis supports CCR7 oligomerization and DC migratory capacity.\",\n      \"evidence\": \"Glycolysis inhibition, oligomerization assays, in vivo DC migration, metabolic profiling\",\n      \"pmids\": [\"29941886\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular link between glycolytic flux and oligomerization not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Resolved CCR7 signaling into spatially organized and modular outputs and uncovered metabolic feedback, including an endomembrane Src-Vav1-Rac1 complex, independent PI3K/MAPK/RhoA modules, HIF-1α glycolytic reprogramming with lnc-Dpf3 feedback, and CXCR4 heteromerization.\",\n      \"evidence\": \"Co-IP, Src mutagenesis, Rac1 photoactivation, pharmacological module dissection, DC-specific lnc-Dpf3 KO with RIP, BRET heteromerization assays\",\n      \"pmids\": [\"31644919\", \"32351499\", \"30824325\", \"31921208\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Integration of the modular pathways into a unified migratory program incomplete\", \"In vivo relevance of CXCR4 heteromer effects limited to B cell models\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established CCR7's role in neutrophil clearance to draining lymph nodes and revealed ACKR4-mediated CCL19/CCL21 scavenging as an external regulator enabling lymphatic transport.\",\n      \"evidence\": \"Neutrophil-specific CCR7 deletion with photoconvertible tracking and S. aureus model; ACKR4-deficient mice with intravital lymphatic imaging\",\n      \"pmids\": [\"35119939\", \"35108538\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crosstalk between cell-intrinsic CCR7 signaling and ACKR4 scavenging not fully integrated\", \"Mechanism of cDC phagocytosis of CCR7+ neutrophils not detailed\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrated CCR7 acts as a chemokine sink shaping its own gradients for collective migration, and as a PI3Kγ-dependent survival signal exploited by lymphoma.\",\n      \"evidence\": \"Microfluidic gradient chambers with live imaging and modeling; CCR7 genetic deletion in ALCL model with PI3Kγ/δ inhibition and PDX\",\n      \"pmids\": [\"37656776\", \"37379367\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo confirmation of self-generated gradients in tissue not established\", \"Therapeutic targeting of CCR7-PI3Kγ axis only tested in limited lymphoma models\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the distinct CCR7 signaling modules, trafficking states, post-translational modifications, and dimerization are integrated in space and time to produce a single coherent migratory response remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified structural model linking C-terminal motifs, ubiquitylation, glycosylation, and dimerization\", \"The ubiquitin ligase and deglycosylating enzymes acting on CCR7 in vivo are unidentified\", \"Quantitative rules governing ligand discrimination between CCL19 and CCL21 signaling outcomes are incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1, 7]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [10, 21]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 7, 21]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [4, 5, 6, 32]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [0, 2, 23]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [20, 25, 31]}\n    ],\n    \"complexes\": [\n      \"CCR7 homodimer\",\n      \"CCR7-CXCR4 heteromer\",\n      \"endomembrane CCR7-Src-Vav1-Rac1 signaling complex\"\n    ],\n    \"partners\": [\n      \"CCL19\",\n      \"CCL21\",\n      \"CXCR4\",\n      \"SRC\",\n      \"VAV1\",\n      \"ARRB (β-arrestin)\",\n      \"RAC1\",\n      \"ACKR4\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}